Pliant Therapeutics Inc Stock Performance
as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
$1.56$1.67
1.27%
Downside
5.70%
Upside
52 Week's Low
52 Week's High
$1.1$16.130.37%
Downside
918.99%
Upside
Pliant Therapeutics Inc share price movements today
- Previous Close
- $1.65
- Open
- $1.67
- Volume
- 831.2K
- Day's Low - High
- $1.56 - $1.67
- 52 Week Low - High
- $1.1 - $16.1
Pliant Therapeutics Inc Historical Returns
- 1 Month Return
- -0.63 %
- 3 Month Return
- + 15.22 %
- 1 Year Return
- -86.75 %
- 3 Year Return
- -93.34 %
- 5 Year Return
- -93.94 %
Pliant Therapeutics Inc Stock Fundamentals & Key Indicators
Check Pliant Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$97.6M
EPS (TTM)
-2.8535
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.69
Industry PE ratio
-3.773885542168675
P/B Ratio
0PEG Ratio
0EBITDA
-218.0M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
2433600.00%
Pliant Therapeutics Inc Stock Valuation
Track how Pliant Therapeutics Inc P/E has moved over time to understand its valuation trends.
Pliant Therapeutics Inc in the last 5 years
Lowest (0.00x)
September 13, 2025
Today (-4.69x)
September 13, 2025
Industry (-3.77x)
September 13, 2025
Highest (-0.42x)
June 30, 2025
Today’s Price to Earnings Ratio: -4.69x
Pliant Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Pliant Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $97.6M | -93.94% | -4.69 | 0.00% | |
| BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
| NA | $37.7B | NA | NA | -3.89% | |
| BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
| BUY | $59.4B | 2.03% | 14.11 | 31.37% |
Stock Returns calculator for Pliant Therapeutics Inc Stock including INR - Dollar returns
The Pliant Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Pliant Therapeutics Inc investment value today
Current value as on today
₹18,306
Returns
Returns from Pliant Therapeutics Inc Stock
Dollar Returns*
₹5,139 (+5.14%)
Analyst Recommendation on Pliant Therapeutics Inc Stock
Based on 20 analysts
95.00%
Buy
5.00%
Hold
0.00%
Sell
Based on 20 analysts, 95% of analysts recommend a 'BUY' rating for Pliant Therapeutics Inc. Average target price of $3.17
Pliant Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Pliant Therapeutics Inc.
What analysts predicted
50.16%UPSIDE
Target Price
$3.17
Current Price
$1.58
Analyzed by
20 Analysts
Target
$3.17
Pliant Therapeutics Inc target price $3.17, a slight upside of 50.16% compared to current price of $1.58. According to 20 analysts rating.
Pliant Therapeutics Inc Stock's Interest Amongst Investors
Search interest for Pliant Therapeutics Inc Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Pliant Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Pliant Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Pliant Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Pliant Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Pliant Therapeutics Inc
Insights on Pliant Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, -56.16M → -43.3M (in $), with an average increase of 29.7% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 162.5%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 218.9%
NEGATIVE IMPACTPrice Dip
In the last 7 days, PLRX stock has moved down by -14.5%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 4.83M → 2.27M (in $), with an average decrease of 53.1% per quarter
About Pliant Therapeutics Inc
| Organisation | Pliant Therapeutics Inc |
| Headquarters | 331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
| Industry | Health Technology |
| CEO | Dr. Bernard Coulie M.B.A., M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Pliant Therapeutics Inc
Name | Title |
|---|---|
Mr. Hal Chapman M.D. | Scientific Founder & Member of Scientific Advisory Board |
Dr. Keith Lamont Cummings M.B.A., M.D. | Chief Financial Officer |
Mr. Johannes P. Hull J.D. | Chief Business Officer |
Dr. Eric A. Lefebvre M.D. | Chief Medical Officer |
Dr. Rik Derynck Ph.D. | Scientific Founder & Member of Scientific Advisory Board |
Mr. Dean Sheppard M.D. | Scientific Founder & Member of Scientific Advisory Board |
Mr. Bill DeGrado Ph.D. | Scientific Founder & Member of Scientific Advisory Board |
Ms. Delphine Imbert Ph.D. | Chief Technical Officer |
Mr. Christopher S. Keenan | Vice President of Investor Relations & Corporate Communications |
Dr. Bernard Coulie M.B.A., M.D., Ph.D. | President, CEO & Director |
FAQs
What is Pliant Therapeutics Inc share price today?
Pliant Therapeutics Inc share price today is $1.58 as on at the close of the market. Pliant Therapeutics Inc share today touched a day high of $1.67 and a low of $1.56.
What is the 52 week high and 52 week low for Pliant Therapeutics Inc share?
Pliant Therapeutics Inc share touched a 52 week high of $16.1 on and a 52 week low of $1.1 on . Pliant Therapeutics Inc stock price today i.e. is closed at $1.58,which is 90.19% down from its 52 week high and 43.62% up from its 52 week low.
What is Pliant Therapeutics Inc's market capitalisation today?
Pliant Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Pliant Therapeutics Inc Stock (PLRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Pliant Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pliant Therapeutics Inc Shares that will get you 0.9494 shares as per Pliant Therapeutics Inc share price of $1.58 per share as on September 13, 2025 at 1:29 am IST.
What is the minimum amount required to buy Pliant Therapeutics Inc Stock (PLRX) from India?
Indian investors can start investing in Pliant Therapeutics Inc (PLRX) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Pliant Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pliant Therapeutics Inc share’s latest price of $1.58 as on September 13, 2025 at 1:29 am IST, you will get 6.3291 shares of Pliant Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Pliant Therapeutics Inc has given to Indian investors in the last 5 years?
Pliant Therapeutics Inc stock has given -93.94% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?